Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

SERA

+ Watchlist+ Portfolio

Sera Prognostics, Inc.

Regulated industrySells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$2.00
52-Week Range
$1.56 – $3.85
Market Cap
$75.96M
P/E (TTM)
—
EPS (TTM)
-0.67
Dividend Yield
0.00%
Advanced Metrics
Price/Book
1.45
PEG Ratio
—
Return on Equity
-49.73%
Return on Assets
-24.72%
Gross Margin
-103.13%
Operating Margin
-38755.21%
Profit Margin
0.00%
Current Ratio
1.88
Debt/Equity
0.06
Total Debt
$3.27M
Free Cash Flow
$-19.17M
Revenue Growth
162.50%
Earnings Growth
—
Enterprise Value
$35.14M

Market Snapshot

About

Sera Prognostics, Inc. is a women's health diagnostic company dedicated to improving maternal and neonatal health. The company develops and commercializes innovative proteomics-based tests to predict pregnancy complications, including preterm birth risk assessment. Sera Prognostics aims to provide healthcare providers with actionable insights to guide prenatal care decisions.